KRYS – Krystal Biotech, Inc.
KRYS — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
13.51
Margin Of Safety %
-5
Put/Call OI Ratio
0.78
EPS Next Q Diff
0.4
EPS Last/This Y
0.73
EPS This/Next Y
1.72
Price
326.22
Target Price
373.88
Analyst Recom
1.25
Performance Q
Upside
-46.2%
Beta
0.52
Ticker: KRYS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | KRYS | 363.23 | 0.68 | 0.00 | 6008 |
| 2026-07-14 | KRYS | 339.43 | 0.68 | 0.18 | 6019 |
| 2026-07-15 | KRYS | 350.59 | 0.68 | 0.08 | 6094 |
| 2026-07-16 | KRYS | 341.48 | 0.67 | 0.07 | 6155 |
| 2026-07-17 | KRYS | 354.8 | 0.67 | 0.21 | 6140 |
| 2026-07-20 | KRYS | 339 | 0.72 | 5.47 | 5670 |
| 2026-07-21 | KRYS | 339.25 | 0.76 | 0.36 | 5847 |
| 2026-07-22 | KRYS | 336.58 | 0.75 | 0.17 | 5956 |
| 2026-07-23 | KRYS | 327.75 | 0.75 | 0.03 | 5968 |
| 2026-07-24 | KRYS | 335.31 | 0.74 | 0.00 | 5996 |
| 2026-07-27 | KRYS | 351.95 | 0.65 | 0.04 | 6498 |
| 2026-07-28 | KRYS | 364.23 | 0.63 | 0.12 | 6670 |
| 2026-07-29 | KRYS | 361.8 | 0.60 | 0.04 | 6961 |
| 2026-07-30 | KRYS | 367.17 | 0.60 | 0.06 | 6962 |
| 2026-07-31 | KRYS | 340 | 0.59 | 1.40 | 7041 |
| 2026-08-03 | KRYS | 312.43 | 0.63 | 2.04 | 7374 |
| 2026-08-04 | KRYS | 324.43 | 0.75 | 0.70 | 8304 |
| 2026-08-05 | KRYS | 325.71 | 0.75 | 1.18 | 8488 |
| 2026-08-06 | KRYS | 322.29 | 0.77 | 0.24 | 8815 |
| 2026-08-07 | KRYS | 326.39 | 0.78 | 0.30 | 8807 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | KRYS | 363.03 | 48.5 | 39.8 | 8.29 |
| 2026-07-14 | KRYS | 339.47 | 48.5 | 26.0 | 8.29 |
| 2026-07-15 | KRYS | 350.30 | 52.7 | 49.2 | 8.42 |
| 2026-07-16 | KRYS | 341.61 | 52.7 | 35.7 | 8.42 |
| 2026-07-17 | KRYS | 354.63 | 54.3 | 50.6 | 8.45 |
| 2026-07-20 | KRYS | 339.24 | 54.3 | 31.1 | 8.45 |
| 2026-07-21 | KRYS | 339.24 | 54.3 | 41.4 | 8.45 |
| 2026-07-22 | KRYS | 336.76 | 51.7 | 39.7 | 8.38 |
| 2026-07-23 | KRYS | 327.77 | 51.7 | 35.4 | 8.38 |
| 2026-07-24 | KRYS | 335.28 | 48.4 | 47.3 | 8.21 |
| 2026-07-27 | KRYS | 351.80 | 48.4 | 53.4 | 8.21 |
| 2026-07-28 | KRYS | 363.70 | 48.4 | 49.5 | 8.21 |
| 2026-07-29 | KRYS | 363.53 | 48.4 | 41.1 | 8.21 |
| 2026-07-30 | KRYS | 367.14 | 48.4 | 44.0 | 8.21 |
| 2026-07-31 | KRYS | 341.05 | 48.4 | 24.8 | 8.21 |
| 2026-08-03 | KRYS | 312.95 | 48.4 | 21.8 | 8.21 |
| 2026-08-04 | KRYS | 312.95 | 48.4 | 21.8 | 8.21 |
| 2026-08-05 | KRYS | 325.56 | -18.7 | 23.1 | 8.21 |
| 2026-08-06 | KRYS | 322.96 | -18.7 | 20.6 | 8.21 |
| 2026-08-07 | KRYS | 326.22 | -31.8 | 31.5 | 7.81 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | KRYS | -5.27 | -1.05 | 13.64 |
| 2026-07-14 | KRYS | -5.27 | -1.05 | 13.64 |
| 2026-07-15 | KRYS | -5.27 | -1.05 | 13.64 |
| 2026-07-16 | KRYS | -5.27 | -1.05 | 13.64 |
| 2026-07-17 | KRYS | -5.27 | -1.05 | 13.64 |
| 2026-07-20 | KRYS | -5.27 | -0.97 | 13.64 |
| 2026-07-21 | KRYS | -5.27 | -0.97 | 13.64 |
| 2026-07-22 | KRYS | -5.27 | -0.97 | 13.64 |
| 2026-07-23 | KRYS | -5.27 | -0.97 | 13.64 |
| 2026-07-24 | KRYS | -5.27 | -0.97 | 13.64 |
| 2026-07-27 | KRYS | -5.27 | -0.99 | 13.56 |
| 2026-07-28 | KRYS | -5.27 | -0.99 | 13.56 |
| 2026-07-29 | KRYS | -5.27 | -0.99 | 13.56 |
| 2026-07-30 | KRYS | -5.27 | -0.99 | 13.56 |
| 2026-07-31 | KRYS | -5.27 | -0.99 | 13.56 |
| 2026-08-03 | KRYS | -5.27 | -0.48 | 13.56 |
| 2026-08-04 | KRYS | -5.27 | -0.48 | 13.56 |
| 2026-08-06 | KRYS | -5.25 | -0.48 | 13.56 |
| 2026-08-07 | KRYS | -5.25 | -0.48 | 13.51 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.79
Avg. EPS Est. Current Quarter
1.81
Avg. EPS Est. Next Quarter
2.19
Insider Transactions
-5.25
Institutional Transactions
-0.48
Beta
0.52
Average Sales Estimate Current Quarter
129
Average Sales Estimate Next Quarter
137
Fair Value
309.14
Quality Score
90
Growth Score
39
Sentiment Score
8
Actual DrawDown %
14.7
Max Drawdown 5-Year %
-44.5
Target Price
373.88
P/E
40.91
Forward P/E
36.07
PEG
1.51
P/S
21.94
P/B
7.11
P/Free Cash Flow
37.48
EPS
7.98
Average EPS Est. Cur. Y
7.81
EPS Next Y. (Est.)
9.53
Target Price Estimates Raised
1
Target Price Estimates Lowered
1
Profit Margin
54.82
Relative Volume
0.37
Return on Equity vs Sector %
-9.6
Return on Equity vs Industry %
6.5
EPS 1 7Days Diff
-0.4
EPS 1 30Days Diff
-0.48
EBIT Estimation
31.5
◆
KRYS
Healthcare
$326.45
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44
Range 1M
33.7%
Sup Dist
2.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
9%
52W%
77.2%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-16.6% upside
Upside
-16.6%
Quality
90
MoS
-5%
KRYS — P/E HistoricalBiotechnology
Krystal Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 295
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
KRYS
Latest News
—
Caricamento notizie per KRYS…
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading